Watchlist Price Alert

Nabriva Therapeutics (NBRV)

NASDAQ: NBRV · Real-Time Price · USD

1.42

0.01 (0.71%)

At close: Jul 31, 2023, 8:00 PM

Nabriva Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	12.41M	47.66M	41.36M	86.02M	102M	86.77M	32.78M
Short-Term Investments	n/a	16K	16K	175K	225K	110K	51.11M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	378K	380K	370K	378K	428K	425K	420K
Receivables	6.74M	12.75M	3.91M	2.74M	5.37M	5.4M	5.56M
Inventory	9.68M	14.51M	5.82M	682K	n/a	n/a	n/a
Other Current Assets	2.27M	5.33M	6.11M	1.55M	1.15M	1.56M	1.18M
Total Current Assets	31.1M	80.27M	57.22M	91.17M	108.75M	93.84M	90.62M
Property-Plant & Equipment	280K	233K	768K	2.47M	1.14M	1.33M	519K
Goodwill & Intangibles	3K	31K	80K	91K	98K	172K	270K
Total Long-Term Assets	661K	644K	1.22M	2.94M	1.67M	1.92M	2.62M
Total Assets	31.77M	80.91M	58.44M	94.11M	110.42M	95.76M	93.24M
Account Payables	5.43M	4.37M	2.89M	4.67M	3.3M	5.14M	2.55M
Deferred Revenue	n/a	374K	750K	n/a	n/a	n/a	n/a
Short-Term Debt	4.83M	3.77M	2.04M	n/a	n/a	n/a	n/a
Other Current Liabilities	17.34M	13.83M	12.84M	11.97M	14.5M	8.12M	13.33M
Total Current Liabilities	27.61M	22.34M	18.52M	16.64M	17.81M	13.26M	15.88M
Long-Term Debt	388K	4.26M	5.69M	34.5M	23.72M	232K	n/a
Other Long-Term Liabilities	479K	954K	1.09M	1.7M	264K	203K	107K
Total Long-Term Liabilities	867K	5.22M	6.78M	36.2M	23.98M	435K	107K
Total Liabilities	28.47M	27.56M	25.3M	52.84M	41.79M	13.7M	15.98M
Total Debt	5.22M	8.03M	7.73M	34.5M	23.72M	232K	n/a
Common Stock	32K	567K	211K	945K	670K	367K	2.94M
Retained Earnings	-652.86M	-595.68M	-546.23M	-476.74M	-393.98M	-279.2M	-204.84M
Comprehensive Income	27K	27K	27K	27K	27K	27K	10K
Shareholders Equity	3.29M	53.35M	33.13M	41.27M	68.63M	82.07M	77.26M
Total Investments	n/a	16K	16K	175K	225K	110K	51.11M